SCHEMBL625456

SCHEMBL625456

CC(C)(C)OC(=O)N1CC(S(=O)(=O)N2CCC(Nc3nn4cc(-c5cnc(N)c(C(F)(F)F)c5)nc4s3)CC2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K12 Q12852 5/20 0.41
CDK2 P24941 2/20 0.39
CCNA2 P20248 1/20 0.39
GPR119 Q8TDV5 1/20 0.38
SYK P43405 1/20 0.38
RIPK1 Q13546 2/20 0.38
PIK3CA P42336 4/20 0.37
CCNT1 O60563 1/20 0.36
CDK1 P06493 1/20 0.36
CDK4 P11802 1/20 0.36
CCNB1 P14635 1/20 0.36
CCND1 P24385 1/20 0.36
CCNE1 P24864 1/20 0.36
CCND3 P30281 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
CCNH P51946 1/20 0.36
MNAT1 P51948 1/20 0.36
CDK6 Q00534 1/20 0.36
AKT1 P31749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625128 0.91 CCNA2 (0.46) MAP3K12CDK2CCNA2GPR119SYK
SCHEMBL625455 0.87 PIK3CA (0.43) MAP3K12GPR119RIPK1PIK3CA
SCHEMBL626207 0.84 MAP3K12 (0.46) MAP3K12CDK2PIK3CACDK1CDK4
SCHEMBL625861 0.83 GPR119 (0.46) CDK2CCNA2GPR119SYKCDK1
SCHEMBL625408 0.83 MAP4K1 (0.39) MAP3K12CDK2CCNA2SYKPIK3CA
SCHEMBL626892 0.82 PIK3CA (0.42) MAP3K12PIK3CAMAP4K1
SCHEMBL624428 0.82 MAP3K12 (0.47) MAP3K12SYKPIK3CA
SCHEMBL625754 0.81 MAP3K12 (0.40) MAP3K12PIK3CA
SCHEMBL624985 0.80 KDM4E (0.40) MAP3K12GPR119SYKPIK3CAMAP4K1
SCHEMBL627309 0.79 MAP3K12 (0.46) MAP3K12PIK3CAMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed